title: Antimurine antibody to OKT3 in cardiac transplantation: implications for prophylaxis and retreatment of rejection.
authors.affiliation: Utah Transplantation Affiliated Hospitals (U.T.A.H.) Cardiac Transplant Program, Salt Lake City.
authors.forename: J B
authors.initials: JB
authors.lastname: O'Connell
authors.forename: M R
authors.initials: MR
authors.lastname: Bristow
authors.forename: E H
authors.initials: EH
authors.lastname: Hammond
authors.forename: R L
authors.initials: RL
authors.lastname: Menlove
authors.forename: R D
authors.initials: RD
authors.lastname: Ensley
authors.forename: R M
authors.initials: RM
authors.lastname: Ratkovec
authors.forename: D G
authors.initials: DG
authors.lastname: Renlund
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000150:complications; D003327:Coronary Disease / Q000150:complications; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D051379:Mice; D016853:Muromonab-CD3; D016019:Survival Analysis
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3